Michael G Kaplitt

USPTO Granted Patents = 14 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 353(Granted Patents)

Location History:

New Rochelle, NY (US) (2010)
New York, NY (US) (2000 - 2014)

Company Filing History:

5 out of 712

The Rockefeller University

Rudolf Magnus Institute

Thomas Jefferson University

patents

7. 1 out of 1

Neurologix Research, Inc.

patent

8. 3 out of 832,761

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2014

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8642341 - Materials and methods for gene mediated therapy of psychiatric disorders (2014-02-04),

2. 8182460 - Infusion device and method for infusing material into the brain of a patient (2012-05-22),

3. 8067156 - Method for generating replication defective viral vectors that are helper free (2011-11-29),

4. 8021838 - Transcriptional regulation of target genes (2011-09-20),

5. 8017385 - Use of apotosis inhibiting compounds in degenerative neurological disorders (2011-09-13),

6. 7955595 - Glutamic acid decarboxylase (GAD) based delivery system (2011-06-07),

7. 7695959 - Glutamic acid decarboxylase (GAD) based delivery systems (2010-04-13),

8. 7645446 - Glutamic acid decarboxylase (GAD) based delivery system (2010-01-12),

9. 6780409 - Glutamic acid decarboxylase (GAD) based delivery system (2004-08-24),

10. 6503888 - AAV-mediated delivery of DNA to cells of the nervous system (2003-01-07),

11. 6180613 - AAV-mediated delivery of DNA to cells of the nervous system (2001-01-30),

12. 6162796 - Method for transferring genes to the heart using AAV vectors (2000-12-19),

13. 6106824 - Expression of growth associated protein B-50/GAP-43 in vitro and in vivo (2000-08-22),

14. 6040172 - Defective DNA viral vector comprising a neural tissue-specific promoter (2000-03-21),

Title: Michael G Kaplitt: Innovator in Gene Therapy and Neurology

Introduction

Michael G Kaplitt is a prominent inventor based in New York, NY, known for his significant contributions to the fields of gene therapy and neurology. With a total of 14 patents to his name, Kaplitt has made remarkable advancements in the treatment of psychiatric disorders and brain infusion techniques.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Materials and methods for gene mediated therapy of psychiatric disorders." This invention provides materials and methods for p11-mediated therapy, which aims to enhance p11 expression and improve treatment responsiveness for psychiatric disorders. Additionally, it introduces model animals for studying depression and its therapies. Another notable patent is the "Infusion device and method for infusing material into the brain of a patient." This device features a flexible guide catheter designed for introduction beneath the skull, allowing for precise infusion of fluids into targeted areas of the brain at extremely low flow rates.

Career Highlights

Kaplitt has held key positions at prestigious institutions, including The Rockefeller University and Neurologix, Inc. His work has been instrumental in advancing the understanding and treatment of neurological conditions.

Collaborations

Throughout his career, Kaplitt has collaborated with notable professionals in the field, including Matthew J During and Joost Verhaagen. These collaborations have further enriched his research and innovations.

Conclusion

Michael G Kaplitt stands out as a leading inventor whose work in gene therapy and neurology continues to impact the medical field significantly. His innovative patents and collaborations reflect his dedication to improving treatment options for psychiatric disorders and advancing neurological research.

This text is generated by artificial intelligence and may not be accurate.